arrow
A

Arnault Tauziède-Espariat

sainte-anne hospital
H指数:27
被引数:2,991

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type

关于一种低级别弥漫性浸润性肿瘤的新观察,<i>SMARCB1</i>突变,论证了一种新的肿瘤类型

2026-09-080
OAAI
Tectal glioma versus pilocytic astrocytoma: revisiting tumor classification in light of molecular heterogeneity

脑桥胶质瘤与毛细胞型星形细胞瘤:基于分子异质性重新审视肿瘤分类

2026-08-200
PRE
BRAFV600E and NRASQ61R Antibodies Are Sensitive and Specific Diagnostic Biomarkers for BRAF and NRAS Mutations in Conjunctival Melanomas

BRAFV600E和NRASQ61R抗体是结膜黑色素瘤中BRAF和NRAS突变敏感且特异性的诊断生物标志物

2026-02-010
PRE
A pediatric case of YAP1::MAML2 fusion-positive supratentorial ependymoma: A potential subtype of YAP1-fused ependymoma

一例YAP1::MAML2融合阳性的幕上室管膜瘤儿科病例:YAP1融合性室管膜瘤的潜在亚型

2026-01-010
PRE
Rare IDH hotspot mutations in dysembryoplastic neuroepithelial tumors expand the spectrum of IDH-altered CNS tumors

少见的IDH热点突变在胚胎发育不良性神经上皮肿瘤中扩展了IDH改变的CNS肿瘤谱

2025-11-180
OAAI
DIFFUSE MIDLINE GLIOMA, H3 K27 AND BRAF/FGFR1 CO-ALTERED: DISTINCT BIOLOGY AND THERAPEUTIC OPPORTUNITIES

弥漫性中线胶质瘤,H3 K27和BRAF/FGFR1共突变:独特的生物学特征和治疗机遇

2025-10-010
OAAI
AI-BASED HISTOPATHOLOGICAL CLASSIFICATION OF CENTRAL NERVOUS SYSTEM TUMOURS

基于人工智能的中央神经系统肿瘤组织病理学分类

2025-10-010
OAAI
UNCOVERING THERAPEUTIC VULNERABILITIES IN PEDIATRIC BCOR/L1-DRIVEN CNS TUMORS THROUGH MULTI-OMICS PROFILING

通过多组学分析揭示儿科BCOR/L1驱动的CNS肿瘤的治疗易感性

2025-10-010
OAAI
Spinal and Leptomeningeal Infantile Glioma With Raf1 Fusion: Diagnostic Challenges for a Potentially Novel Tumour Type

脊柱和软脑膜婴幼儿胶质瘤伴Raf1融合:一种潜在新型肿瘤类型的诊断挑战

2025-08-130
PRE
Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype
2024-11-180
OAAI
MOLECULAR SUBTYPES, CLINICAL CHARACTERISTICS, AND THERAPEUTIC IMPLICATIONS FOR CNS TUMORS WITH BCOR/BCORL1 FUSION/INTERNAL TANDEM DUPLICATION
2024-11-110
PRE